AI3 Bio, Inc.
Filing history at a glance
The displayed Nov 4, 2026 filing reports $0 sold and has no numeric offering amount in the explorer. From Apr 30, 2025 to Nov 4, 2026, the explorer stores 3 original notices and 2 amendments.
through Nov 4, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
Both filings have the same date. Their sequence is unknown; directional differences are suppressed.
| Field | Nov 4, 2026 · D | Nov 4, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $48,339,490 | — | — |
| Reported amount sold | $48,339,490 | $0 | — |
| Reported investor count | 8 | 7 | — |
| Reported minimum investment | $0 | $0 | — |
Earlier SEC source: 0002019875-26-000003 · Later SEC source: 0002019875-26-000004
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- —
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $0
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20253 filings
- 20262 filings
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (5)
-
0002019875-26-000004D · Nov 4, 2026 · BiotechnologySold: $0
Same filing date; order cannot be established.
-
0002019875-26-000003D · Nov 4, 2026 · BiotechnologyOffering: $48,339,490Sold: $48,339,490
Compared with 0002019875-25-000004:
- Reported offering amount: $16,754,446 → $48,339,490
- Reported amount sold: $16,754,446 → $48,339,490
- Reported investor count: Unavailable → 8
-
0002019875-25-000004D · Oct 20, 2025 · PharmaceuticalsOffering: $16,754,446Sold: $16,754,446
Compared with 0002019875-25-000002:
- Reported offering amount: $63,455,390 → $16,754,446
- Reported amount sold: $58,510,656 → $16,754,446
-
0002019875-25-000002D/A · Aug 11, 2025 · PharmaceuticalsOffering: $63,455,390Sold: $58,510,656
Compared with 0002019875-25-000001:
- Reported offering amount: $53,681,969 → $63,455,390
- Reported amount sold: $53,441,210 → $58,510,656
-
0002019875-25-000001D/A · Apr 30, 2025 · PharmaceuticalsOffering: $53,681,969Sold: $53,441,210